The Medicines and Healthcare products Regulatory Agency (MHRA) has approved trofolastat (RoTecPSMA), the first prostate-specific membrane antigen (PSMA)-targeting product authorised for use with ...

"The MHRA has long been regarded as a well-respected ... New Boehringer US Head Brian Hilberdink talks GLP-1s, DTx an... At Reuters Pharma USA, editor-in-chief Jonah Comstock caught up with ...

All GLP-1 and dual GIP/GLP-1 receptor agonists slow ... This can potentially lead to severe complications.' The MHRA said there had been a small number of reports of patients on the jabs suffering ...

The figures are provided by country's medicine regulator, the Medicines and Healthcare Products Regulatory Agency (MHRA). The ...